M.-Z. Cai et al. / Journal of Organometallic Chemistry 693 (2008) 2954–2958
2957
(M+À1, 5.3), 361 (100), 177 (50); Anal. Calc. for C22H34Sn: C, 63.33;
45 (100); Anal. Calc. for C18H35OBrSn: C, 46.38; H, 7.57. Found: C,
46.11; H, 7.72%.
H, 8.21. Found: C, 63.11; H, 8.02%.
3.2.3. (Z)-3-(Tributylstannyl)-5-methoxylpent-3-en-1-yne (3c)
3.3.4. (1E,3Z)-1-Bromo-3-(tributylstannyl)-1,3-decadiene 5d
IR (film):
m
(cmÀ1) 3314, 2957, 2929, 2066, 1713, 1590, 1456,
IR (film):
m
(cmÀ1) 2919, 1683, 1576, 1464, 960, 737; 1H NMR
3
3
1124; 1H NMR (CDCl3): d 6.88 (t, J = 5.6 Hz, JSn–H = 102 Hz, 1H),
3.95 (d, J = 5.6 Hz, 2H), 3.33 (s, 3H), 3.22 (s, 1H), 1.58–1.48 (m,
6H), 1.37–1.27 (m, 6H), 1.02 (t, J = 8.0 Hz, 6H), 0.92–0.88 (m, 9H);
13C NMR (CDCl3): d 149.4, 126.8, 87.6, 80.6, 73.6, 58.2, 28.9, 27.3,
13.7, 11.4; MS: m/z 386 (M+, 4.1), 329 (65), 291 (39), 235 (64),
177 (100); Anal. Calc. for C18H34OSn: C, 56.13; H, 8.90. Found: C,
56.37; H, 9.12%.
(CDCl3): d 6.85 (d, J = 13.6 Hz, 1H), 6.27 (t, J = 7.2 Hz, JSn–H
=
108 Hz, 1H), 6.02 (d, J = 13.6 Hz, 1H), 2.07–1.98 (m, 2H), 1.60–
1.24 (m, 20H), 0.97–0.82 (m, 18H); 13C NMR (CDCl3): d 147.0,
145.3, 139.3, 103.2, 34.6, 31.8, 29.8, 29.1, 29.0, 27.3, 22.6, 14.1,
13.7, 11.0; MS: m/z 507 (M+, 1.2), 450 (78), 291 (39), 177 (100),
57 (56); Anal. Calc. for C22H43BrSn: C, 52.19; H, 8.56. Found: C,
52.41; H, 8.72%.
3.2.4. (Z)-3-(Tributylstannyl)dec-3-en-1-yne (3d)
3.3.5. (1E,3Z)-1-Iodo-3-(tributylstannyl)-1,3-octadiene 5e
IR (film):
m
(cmÀ1) 3314, 2958, 2928, 2071, 1713, 1586, 1464; 1H
IR (film): m
(cmÀ1) 2959, 2927, 1682, 1567, 1463, 962; 1H NMR
NMR (CDCl3): d 6.82 (t, J = 7.6 Hz, 3JSn–H = 108 Hz, 1H), 3.07 (s, 1H),
2.11–2.02 (m, 2H), 1.56–1.48 (m, 6H), 1.37–1.28 (m, 14H), 1.05–
0.87 (m, 18H); 13C NMR (CDCl3): d 155.5, 122.6, 88.2, 77.7, 35.7,
31.8, 29.5, 29.1, 29.0, 27.3, 22.6, 14.1, 13.7, 10.8; MS: m/z 426
(M+, 1.4), 369 (40), 363 (100), 291 (32), 177 (34); Anal. Calc. for
(CDCl3): d 6.70 (d, J = 13.6 Hz, 1H), 6.61 (d, J = 13.6 Hz, 1H), 5.92 (t,
3
J = 7.2 Hz, JSn–H = 108 Hz, 1H), 2.30–2.21 (m, 2H), 1.62–1.25 (m,
22H), 0.95–0.87 (m, 12H); 13C NMR (CDCl3): d 146.2, 142.4,
105.4, 83.8, 35.9, 30.2, 29.2, 26.6, 22.3, 13.9, 13.6, 11.4; MS: m/z
469 (M+ÀBu, 38), 291 (47), 57 (100); Anal. Calc. for C20H39SnI: C,
45.74; H, 7.49. Found: C, 45.58; H, 7.26%.
C22H42Sn: C, 62.13; H, 9.95. Found: C, 62.29; H, 10.22%.
3.3. General procedure for the synthesis of (1E,3Z)-1-halo-3-
(tributylstannyl)-substituted 1,3-dienes 5a–h
3.3.6. (1E,3Z)-1-Iodo-3-(tributylstannyl)-4-phenyl-1,3-butadiene 5f
IR (film): m
(cmÀ1) 2957, 2921, 1566, 1492, 1463, 967, 759, 690;
1H NMR (CDCl3): d 7.61–7.56 (m, 2H), 7.40–7.32 (m, 3H), 7.05 (s,
3JSn–H = 108 Hz, 1H), 6.92 (d, J = 13.6 Hz, 1H), 6.85 (d, J = 13.6 Hz,
1H), 1.68–1.59 (m, 6H), 1.45–1.26 (m, 12H), 0.95–0.92 (m, 9H);
13C NMR (CDCl3): d 149.1, 143.7, 129.1, 128.5, 128.3, 128.2,
102.6, 86.7, 29.1, 26.7, 13.6, 11.3; MS: m/z 489 (M+ÀBu, 63), 291
(43), 177 (100), 77 (61); Anal. Calc. for C22H35SnI: C, 48.47; H,
6.47. Found: C, 48.20; H, 6.60%.
A dry 10 ml round-bottomed flask was charged with Cp2Zr(H)Cl
(1.05 mmol) under Ar. THF (4 ml) was injected, followed by addi-
tion of (Z)-3-(tributylstannyl)alk-3-en-1-yne 3 (1 mmol). The mix-
ture was stirred for 40 min at room temperature to yield a clear
solution. It was then added dropwise a solution of iodine or NBS
(1 mmol) in THF (2 ml) at 0 °C over 15 min and stirred at room
temperature for 1 h. The mixture was diluted with diethyl ether
(30 ml) and the mixture was filtered through a short plug of silica
gel and concentrated to give a residue. The residue was purified by
preparative TLC on silica gel eluting with light petroleum ether (bp
30–60 °C).
3.3.7. (1E,3Z)-1-Iodo-3-(tributylstannyl)-5-methoxy-1,3-pentadiene
5g
IR (film):
m
(cmÀ1) 2919, 2850, 1589, 1456, 1123, 961; 1H NMR
3
(CDCl3): d 7.18 (d, J = 13.6 Hz, 1H), 6.36 (t, J = 5.4 Hz, JSn–H
=
108 Hz, 1H), 6.10 (d, J = 13.6 Hz, 1H), 3.89 (d, J = 5.4 Hz, 2H), 3.33
(s, 3H), 1.54–1.41 (m, 6H), 1.39–1.26 (m, 6H), 1.05–0.85 (m,
15H); 13C NMR (CDCl3): d 152.2, 146.3, 140.5, 75.2, 73.2, 58.2,
29.1, 27.4, 13.7, 11.2; MS: m/z 514 (M+, 1.4), 457 (67), 291 (36),
45 (100); Anal. Calc. for C18H35OSnI: C, 42.14; H, 6.88. Found: C,
42.39; H, 6.97%.
3.3.1. (1E,3Z)-1-Bromo-3-(tributylstannyl)-1,3-octadiene 5a
IR (film):
(CDCl3):
m
(cmÀ1) 2957, 2925, 1577, 1464, 960; 1H NMR
3
d
6.84 (d, J = 13.6 Hz, 1H), 6.27 (t, J = 7.2 Hz, JSn–
H = 108 Hz, 1H), 6.02 (d, J = 13.6 Hz, 1H), 2.07–1.98 (m, 2H),
1.51–1.24 (m, 16H), 0.99–0.85 (m, 18H); 13C NMR (CDCl3): d
147.0, 145.3, 139.3, 103.2, 34.3, 32.0, 29.1, 27.3, 22.6, 14.1,
13.7, 11.0; MS: m/z 479 (M+, 1.6), 422 (65), 291 (43), 57 (100);
Anal. Calc. for C20H39BrSn: C, 50.23; H, 8.22. Found: C, 50.39; H,
8.41%.
3.3.8. (1E,3Z)-1-Iodo-3-(tributylstannyl)-1,3-decadiene 5h
IR (film):
m
(cmÀ1) 2955, 2926, 1683, 1464, 961; 1H NMR
(CDCl3): d 6.70 (d, J = 13.6 Hz, 1H), 6.60 (d, J = 13.6 Hz, 1H), 5.93
3
(t, J = 7.2 Hz, JSn–H = 108 Hz, 1H), 2.26–2.20 (m, 2H), 1.59–1.21
3.3.2. (1E,3Z)-1-Bromo-3-(tributylstannyl)-4-phenyl-1,3-butadiene
(m, 26H), 0.95–0.82 (m, 12H); 13C NMR (CDCl3): d 146.1, 142.5,
105.5, 83.9, 36.2, 31.7, 29.8, 29.4, 28.9, 27.5, 22.6, 14.1, 13.8,
11.2; MS: m/z 497 (M+ÀBu, 43), 291 (33), 177 (100), 57 (62); Anal.
Calc. for C22H43SnI: C, 47.77; H, 7.84. Found: C, 47.51; H, 7.62%.
5b
IR (film):
m
(cmÀ1) 2957, 2918, 1708, 1560, 1489, 1455, 961,
770, 698; 1H NMR (CDCl3): d 7.41 (s, JSn–H = 108 Hz, 1H), 7.32–
7.19 (m, 5H), 7.03 (d, J = 13.6 Hz, 1H), 6.21 (d, J = 13.6 Hz, 1H),
1.38–1.16 (m, 12H), 0.92–0.83 (m, 15H); 13C NMR (CDCl3): d
145.2, 144.4, 143.9, 140.2, 128.2, 128.0, 127.6, 105.2, 28.9, 27.2,
13.7, 11.5; MS: m/z 499 (M+, 1.3), 442 (75), 291 (54), 177 (100),
77 (52); Anal. Calc. for C22H35BrSn: C, 53.04; H, 7.08. Found: C,
53.23; H, 7.32%.
3
3.4. Synthesis of 1,3-dienylstannanes 6a–b
To a mixture of (1E,3Z)-1-bromo-3-(tributylstannyl)-1,3-octadi-
ene 5a (1 mmol) and NiCl2(dppe) (0.03 mmol) in THF (2 ml) was
added a solution of RMgBr (1.5 mmol) in THF (3 ml) under Ar at
0 °C with stirring. The resulting mixture was slowly brought to
room temperature and stirred for 2 h. The mixture was treated
with sat. NH4Cl aq. solution (15 ml) at 0 °C and extracted with
diethyl ether (2 Â 30 ml). The ethereal solution was washed with
water (2 Â 20 ml) and dried (MgSO4). Removal of the solvent under
reduced pressure gave an oil, which was purified by preparative
TLC on silica gel eluting with light petroleum ether (bp 30–
3.3.3. (1E,3Z)-1-Bromo-3-(tributylstannyl)-5-methoxy-1,3-
pentadiene 5c
IR (film):
m
(cmÀ1) 2957, 2922, 1715, 1573, 1456, 1124, 960; 1H
3
NMR (CDCl3): d 6.87 (d, J = 13.6 Hz, 1H), 6.36 (t, J = 6.0 Hz, JSn–H
=
108 Hz, 1H), 6.11 (d, J = 13.6 Hz, 1H), 3.90 (d, J = 6.0 Hz, 2H), 3.33
(s, 3H), 1.52–1.41 (m, 6H), 1.38–1.25 (m, 6H), 1.04–0.85 (m,
15H); 13C NMR (CDCl3): d 144.4, 143.6, 140.5, 104.7, 73.3, 58.2,
29.1, 27.3, 13.7, 11.4; MS: m/z 467 (M+, 2.3), 410 (63), 291 (47),
60 °C). Compound 6a: oil. IR (film):
1589, 1464, 1378, 961; 1H NMR (CDCl3): d 6.25–6.19 (m, 2H),
m
(cmÀ1) 3024, 2925, 2872,